137 related articles for article (PubMed ID: 11394903)
1. Soyasaponin I, a potent and specific sialyltransferase inhibitor.
Wu CY; Hsu CC; Chen ST; Tsai YC
Biochem Biophys Res Commun; 2001 Jun; 284(2):466-9. PubMed ID: 11394903
[TBL] [Abstract][Full Text] [Related]
2. Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids.
Hsu CC; Lin TW; Chang WW; Wu CY; Lo WH; Wang PH; Tsai YC
Gynecol Oncol; 2005 Feb; 96(2):415-22. PubMed ID: 15661230
[TBL] [Abstract][Full Text] [Related]
3. Different reactivity of two brain sialyltransferases towards sulfhydryl reagents. Evidence for a thiol group involved in the nucleotide-sugar binding site of the NeuAc alpha 2-3Gal beta 1-3GalNAc alpha(2-6)sialyltransferase.
Baubichon-Cortay H; Broquet P; George P; Louisot P
Glycoconj J; 1989; 6(1):115-27. PubMed ID: 2485232
[TBL] [Abstract][Full Text] [Related]
4. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
[TBL] [Abstract][Full Text] [Related]
5. Studies on the inhibition of sialyl- and galactosyltransferases.
Kleineidam RG; Schmelter T; Schwarz RT; Schauer R
Glycoconj J; 1997 Jan; 14(1):57-66. PubMed ID: 9076514
[TBL] [Abstract][Full Text] [Related]
6. Ecto-sialyltransferase of human B lymphocytes reconstitutes differentiation markers in the presence of exogenous CMP-N-acetyl neuraminic acid.
Gross HJ; Merling A; Moldenhauer G; Schwartz-Albiez R
Blood; 1996 Jun; 87(12):5113-26. PubMed ID: 8652824
[TBL] [Abstract][Full Text] [Related]
7. The Hexapeptide inhibitor of Galbeta 1,3GalNAc-specific alpha 2,3-sialyltransferase as a generic inhibitor of sialyltransferases.
Lee KY; Kim HG; Hwang MR; Chae JI; Yang JM; Lee YC; Choo YK; Lee YI; Lee SS; Do SI
J Biol Chem; 2002 Dec; 277(51):49341-51. PubMed ID: 12379642
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Bacterial α(2,6)-Sialyltransferase Reaction through an Inhibition of Its Inherent Sialidase Activity by Dephosphorylation of Cytidine-5'-Monophosphate.
Kang JY; Lim SJ; Kwon O; Lee SG; Kim HH; Oh DB
PLoS One; 2015; 10(7):e0133739. PubMed ID: 26231036
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of bisubstrate and donor analogues of sialyltransferase and their inhibitory activities.
Izumi M; Wada K; Yuasa H; Hashimoto H
J Org Chem; 2005 Oct; 70(22):8817-24. PubMed ID: 16238314
[TBL] [Abstract][Full Text] [Related]
10. α2,3-sialyltransferase type I regulates migration and peritoneal dissemination of ovarian cancer cells.
Wen KC; Sung PL; Hsieh SL; Chou YT; Lee OK; Wu CW; Wang PH
Oncotarget; 2017 Apr; 8(17):29013-29027. PubMed ID: 28423672
[TBL] [Abstract][Full Text] [Related]
11. Sialyltransferase inhibition and recent advances.
Wang L; Liu Y; Wu L; Sun XL
Biochim Biophys Acta; 2016 Jan; 1864(1):143-53. PubMed ID: 26192491
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of alpha/beta-galactoside alpha2,3-sialyltransferase from a luminous marine bacterium, Photobacterium phosphoreum.
Iwatani T; Okino N; Sakakura M; Kajiwara H; Takakura Y; Kimura M; Ito M; Yamamoto T; Kakuta Y
FEBS Lett; 2009 Jun; 583(12):2083-7. PubMed ID: 19467231
[TBL] [Abstract][Full Text] [Related]
13. Conformational and electrostatic analysis of S
Crous W; Naidoo KJ
Bioorg Med Chem; 2016 Oct; 24(20):4998-5005. PubMed ID: 27614914
[TBL] [Abstract][Full Text] [Related]
14. Microbial glycosyltransferases for carbohydrate synthesis: alpha-2,3-sialyltransferase from Neisseria gonorrheae.
Izumi M; Shen GJ; Wacowich-Sgarbi S; Nakatani T; Plettenburg O; Wong CH
J Am Chem Soc; 2001 Nov; 123(44):10909-18. PubMed ID: 11686694
[TBL] [Abstract][Full Text] [Related]
15. Structure-based mutagenic analysis of mechanism and substrate specificity in mammalian glycosyltransferases: porcine ST3Gal-I.
Rakic B; Rao FV; Freimann K; Wakarchuk W; Strynadka NC; Withers SG
Glycobiology; 2013 May; 23(5):536-45. PubMed ID: 23300007
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of CMP-9''-modified-sialic acids as donor substrate analogues for mammalian and bacterial sialyltransferases.
Kajihara Y; Kamitani T; Sato R; Kamei N; Miyazaki T; Okamoto R; Sakakibara T; Tsuji T; Yamamoto T
Carbohydr Res; 2007 Sep; 342(12-13):1680-8. PubMed ID: 17572399
[TBL] [Abstract][Full Text] [Related]
17. Stachybotrydial, a potent inhibitor of fucosyltransferase and sialyltransferase.
Lin TW; Chang WW; Chen CC; Tsai YC
Biochem Biophys Res Commun; 2005 Jun; 331(4):953-7. PubMed ID: 15882970
[TBL] [Abstract][Full Text] [Related]
18. The biochemical consequences of alpha2,6(N) sialyltransferase induction by dexamethasone on sialoglycoprotein expression in the rat H411e hepatoma cell line.
Coughlan CM; Burger PG; Berger EG; Breen KC
FEBS Lett; 1997 Aug; 413(2):389-93. PubMed ID: 9280318
[TBL] [Abstract][Full Text] [Related]
19. Highly Substituted Cyclopentane-CMP Conjugates as Potent Sialyltransferase Inhibitors.
Li W; Niu Y; Xiong DC; Cao X; Ye XS
J Med Chem; 2015 Oct; 58(20):7972-90. PubMed ID: 26406919
[TBL] [Abstract][Full Text] [Related]
20. CMP substitutions preferentially inhibit polysialic acid synthesis.
Miyazaki T; Angata K; Seeberger PH; Hindsgaul O; Fukuda M
Glycobiology; 2008 Feb; 18(2):187-94. PubMed ID: 18077550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
